• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
JIANG Yifeng,TANG Yiqun.Role of TRPM7 in diabetic myocardial fibrosis[J].Journal Of Pharmaceutical Research,2023,42(5):326-329[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2904times   Download 2397次 QR Code for this article
Scan with your phone!
TRPM7在糖尿病心肌纤维化中的作用
蒋一枫,汤依群
Font:Larger+|Default|Smaller-
(中国药科大学,江苏 南京 211198)
摘要:
糖尿病心肌病(Diabetic cardiomyopathy,DCM)是糖尿病(Diabetes mellitus,DM)恶化到一定阶段后出现的心血管并发症。纤维化是其中重要的病理重构,主要由心脏成纤维细胞(Cardiac fibroblasts,CFs)参与。TRPM7(Transient receptor potential melastatin-subfamily member 7)是一种具有阳离子通道和蛋白激酶双重结构的膜蛋白,组成性表达于心脏成纤维细胞中。TRPM7在糖尿病心肌纤维化的病理过程中发挥着重要作用,能够通过影响转化生长因子β1(Transforming growth factor β1,TGF-β1)的表达、肾素-血管紧张素-醛固酮系统(Renin-angiotensin-aldosterone system,RAAS)的活化、Ca2+的信号转导和Mg2+的代谢,从而影响糖尿病心肌纤维化的发展进程。本文综述TRPM7在糖尿病心肌纤维化中的广泛和重要作用,并关注了其作为减轻纤维发生的治疗靶点的潜力。
关键词:  糖尿病心肌病  心脏纤维化  成纤维细胞  TRPM7
DOI:10.13506/j.cnki.jpr.2023.05.007
基金项目:国家科技重大专项(No.2017ZX09301066)
Publication Date:May 25, 2023
Role of TRPM7 in diabetic myocardial fibrosis
JIANG Yifeng,TANG Yiqun
(China Pharmaceutical University, Nanjing 211198, China)
Abstract:
Diabetic cardiomyopathy (DCM) is a cardiovascular complication after diabetes mellitus (DM) develops to a certain stage. Fibrosis is one of the important pathological reconstruction, which mainly involving cardiac fibroblasts (CFs). TRPM7 (Transient receptor potential mela statin-subfamily member 7) is a membrane protein with dual structure of cation channel and protein kinase, which is constitutively expressed in cardiac fibroblasts. TRPM7 plays an important role in the pathological process of diabetic cardiac fibrosis. It can impact the development of diabetic cardiac fibrosis by influencing expression of transforming growth factor β1(TGF-β1), activation of renin-angiotensin-aldosterone system (RAAS), signal transduction of Ca2+ and metabolization of Mg2+. This article discussed the extensive and important role of TRPM7 in diabetic cardiac fibrosis, and pays attention to its potential as a therapeutic target to reduce fibrosis.
Key words:  Diabetic cardiomyopathy  Myocardial fibrosis  Fibroblast  TRPM7
Today's Visits:488    Total Visits:2383203
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.